Study links protein to breast cancer

2012-12-28 23:01


Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Hong Kong - The discovery that a protein which triggers milk production in women may also be responsible for making breast cancers aggressive could open up new opportunities for treatment of the most common and deadliest form of cancer among women.

Found in all breast cells, the protein ELF5 tries to activate milk production even in breast cancer cells, which does not work and then makes the cancer more aggressive, according to scientists in Australia and Britain.

"The discovery opens up new avenues for therapy and for designing new markers that can predict response to therapy," said lead author Professor Chris Ormandy from the Garvan Institute of Medical Research in Sydney.

In 2008, Ormandy's work linked ELF5 to milk production.

The latest research by Ormandy and his team, published in the journal Plos Biology on Friday, went a step further to find the link between ELF5 and breast cancer.

Cancer deaths

"Cancer cells can't respond properly [to ELF5], so they... acquire some characteristics... that make the disease more aggressive and more refractory [resistant] to treatment with existing therapies," Ormandy said by telephone.

Ormandy and his team grew human breast cancer tissues, genetically manipulated to contain high amounts of ELF5, in petri dishes and saw how the protein proliferated aggressively.

Breast cancer is the most commonly diagnosed cancer and the top cause of cancer death among women, accounting for 23% of total cancer cases and 14% of cancer deaths in women.

To decide on treatment, doctors normally need to find out if the cancer has receptors for the hormones oestrogen and progesterone, which, in the case of breast cancer patients, promote growth in their tumours.

Two-thirds of breast cancers are usually positive for oestrogen receptors, which then require anti-hormonal therapies that lower oestrogen levels in the patient or block oestrogen from supporting the growth of the cancer.

For the remaining one-third of patients, their cancers do not have receptors, which means they won't benefit from hormonal therapies. Such patients are usually given other treatments, such as chemotherapy.

Ormandy's team found that cancers with these receptors had low levels of ELF5, while those without receptors had significantly higher levels of the protein.

"What we have shown in this paper is high ELF5 tumours are dependent on ELF5 for their proliferation and if we block ELF5 in high ELF5 tumours, we will block proliferation and that will treat the tumour," Ormandy said.

"If we can develop a drug that targets ELF5, it will be very useful for that group of women," he said.

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.
Read more on:    technology  |  health
NEXT ON NEWS24X publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
1 comment
Comments have been closed for this article.

Inside News24


Rugby World Cup 2015

All the action from the 2015 RWC, including live coverage of all 48 matches, breaking news, fixtures, results, logs - and much more!


Rugby World Cup 2015

VIDEO: 'British media were raving about Lood, Eben'
No '07 France ghosts - Foster
Boks not underestimating Wales scrum
Boks play repeat knockout at RWC
Traffic Alerts

You may find it hard to focus on the mundane routines as the greener pastures seem so tempting. It is a good time to expand more

There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.